Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | dopamine receptor D3 | Starlite/ChEMBL | References |
Homo sapiens | dopamine receptor D2 | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | dopamine receptor D3 | 400 aa | 392 aa | 19.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0022 | 0.036 | 0.0328 |
Toxoplasma gondii | Erv1 / Alr family protein | 0.0038 | 0.0825 | 0.2153 |
Brugia malayi | beta-lactamase family protein | 0.004 | 0.088 | 0.1064 |
Trypanosoma brucei | hypothetical protein, conserved | 0.004 | 0.088 | 0.2409 |
Echinococcus multilocularis | FAD linked sulfhydryl oxidase ALR | 0.0038 | 0.0825 | 0.1862 |
Leishmania major | telomerase reverse transcriptase, putative | 0.0095 | 0.2519 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.088 | 0.1278 |
Mycobacterium ulcerans | beta-lactamase | 0.004 | 0.088 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0038 | 0.0825 | 0.2153 |
Trypanosoma brucei | telomerase reverse transcriptase | 0.0095 | 0.2519 | 1 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.004 | 0.088 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.088 | 0.1278 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0047 | 0.1096 | 1 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0043 | 0.098 | 0.5 |
Toxoplasma gondii | Erv1 / Alr family protein | 0.0038 | 0.0825 | 0.2153 |
Leishmania major | hypothetical protein, conserved | 0.004 | 0.088 | 0.2409 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0047 | 0.1096 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.004 | 0.088 | 0.2409 |
Mycobacterium leprae | Probable lipase LipE | 0.004 | 0.088 | 0.5 |
Plasmodium vivax | telomerase reverse transcriptase, putative | 0.0095 | 0.2519 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.088 | 0.1278 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.004 | 0.088 | 0.2409 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0095 | 0.2519 | 1 |
Brugia malayi | beta-lactamase | 0.004 | 0.088 | 0.1064 |
Trypanosoma brucei | ERV/ALR sulfhydryl oxidase domain-containing protein | 0.0038 | 0.0825 | 0.2153 |
Brugia malayi | beta-lactamase family protein | 0.004 | 0.088 | 0.1064 |
Echinococcus granulosus | FAD linked sulfhydryl oxidase ALR | 0.0038 | 0.0825 | 0.192 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0047 | 0.1096 | 0.3408 |
Mycobacterium ulcerans | lipase LipD | 0.004 | 0.088 | 0.5 |
Giardia lamblia | Telomerase catalytic subunit | 0.0095 | 0.2519 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.088 | 0.1278 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.088 | 0.1278 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.004 | 0.088 | 0.1987 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.016 | 0.4429 | 0.6091 |
Loa Loa (eye worm) | beta-lactamase | 0.004 | 0.088 | 0.1278 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.004 | 0.088 | 0.1278 |
Trypanosoma cruzi | Present in the outer mitochondrial membrane proteome 4 | 0.0038 | 0.0825 | 0.2153 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.004 | 0.088 | 0.5 |
Trypanosoma cruzi | ERV/ALR sulfhydryl oxidase domain-containing protein | 0.0038 | 0.0825 | 0.2153 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0047 | 0.1096 | 0.255 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.004 | 0.088 | 0.1987 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.004 | 0.088 | 0.2409 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0047 | 0.1096 | 0.3408 |
Brugia malayi | Augmenter of liver regeneration | 0.0038 | 0.0825 | 0.0986 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.004 | 0.088 | 0.1064 |
Plasmodium falciparum | FAD-linked sulfhydryl oxidase ERV1, putative | 0.0038 | 0.0825 | 0.2153 |
Toxoplasma gondii | ABC1 family protein | 0.004 | 0.088 | 0.2409 |
Toxoplasma gondii | RNA-directed DNA polymerase | 0.0095 | 0.2519 | 1 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0047 | 0.1096 | 0.3408 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.004 | 0.088 | 0.2048 |
Mycobacterium leprae | conserved hypothetical protein | 0.004 | 0.088 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.004 | 0.088 | 0.5 |
Loa Loa (eye worm) | hepatopoietin HPO2 | 0.0038 | 0.0825 | 0.1142 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.016 | 0.4429 | 1 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.016 | 0.4429 | 1 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0095 | 0.2519 | 1 |
Loa Loa (eye worm) | acetyltransferase | 0.016 | 0.4429 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.004 | 0.088 | 0.1987 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0155 | 0.4296 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0253 | 0.7201 | 1 |
Trypanosoma cruzi | Present in the outer mitochondrial membrane proteome 4 | 0.0038 | 0.0825 | 0.2153 |
Brugia malayi | Telomerase reverse transcriptase | 0.0253 | 0.7189 | 1 |
Plasmodium vivax | FAD-linked sulfhydryl oxidase ERV1, putative | 0.0038 | 0.0825 | 0.2153 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.088 | 0.1278 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0043 | 0.098 | 0.2872 |
Plasmodium falciparum | telomerase reverse transcriptase | 0.0095 | 0.2519 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | Antagonist activity at human dopamine D3 receptor expressed in CHO-K1 cells assessed as inhibition of dopamine-induced recruitment of beta-arrestin-2 after 90 mins by beta-galactosidase assay | ChEMBL. | 21495689 | |
IC50 (functional) | Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis | ChEMBL. | 21495689 | |
IC50 (functional) | = 918 nM | Antagonist activity at human dopamine D3 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis | ChEMBL. | 21495689 |
Inhibition (binding) | < 50 % | Displacement of [3H]8-OH-DPAT from 5HT1A receptor at 10 uM | ChEMBL. | 21495689 |
Ki (binding) | = 393 nM | Displacement of [125I]-IABN from human dopamine D3 receptor expressed in HEK293 cells after 60 mins by gamma counting | ChEMBL. | 21495689 |
Ki (binding) | = 2060 nM | Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting | ChEMBL. | 21495689 |
Ki (binding) | = 2580 nM | Displacement of [125I]DOI from 5HT2A receptor | ChEMBL. | 21495689 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.